12:00 AM
 | 
Apr 21, 2008
 |  BioCentury  |  Finance

EPS watch

EPS watch

Company 1Q08 EPS est 1Q08 EPS actual Outcome Growth from 1Q07 4/18 cls Wk chg % chg Mcap chg 4/18 Mcap
Abbott (NYSE:ABT) $0.62 $0.63 Beat by $0.01 15% $50.72 -$2.08 -4% -$3,246.0 $79,152.0
1Q08 sales were up 13.8% to $6.8B from $5.3B in 1Q07. Global sales of Humira adalimumab rose 53.7% to $878M from $571M in 1Q07. The company gave 2008 non-GAAP EPS guidance of $3.20-$3.25 and 2Q08 non-GAAP EPS guidance of $0.78-$0.80 All figures include foreign currency exchange impact.
Cubist (NASDAQ:CBST)

Read the full 526 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >